Hongfeng Deng

1.7k total citations
15 papers, 1.1k citations indexed

About

Hongfeng Deng is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hongfeng Deng has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hongfeng Deng's work include Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Forensic Toxicology and Drug Analysis (3 papers). Hongfeng Deng is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Forensic Toxicology and Drug Analysis (3 papers). Hongfeng Deng collaborates with scholars based in United States, France and Italy. Hongfeng Deng's co-authors include Alexandros Makriyannis, Heriberto P. Mata, Frank Porreca, Todd W. Vanderah, Mohab Ibrahim, Qian Liu, Philip T. Malan, A. M. Zvonok, Debra A. Cockayne and T. Philip Malan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Pain.

In The Last Decade

Hongfeng Deng

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongfeng Deng United States 11 798 498 254 247 144 15 1.1k
Laura Rauser United States 10 226 0.3× 433 0.9× 552 2.2× 158 0.6× 40 0.3× 11 1.4k
Clara Andradas Spain 13 678 0.8× 273 0.5× 324 1.3× 66 0.3× 29 0.2× 16 972
Edurne Cenarruzabeitia Spain 18 136 0.2× 275 0.6× 369 1.5× 89 0.4× 112 0.8× 50 866
Giulia Donvito United States 11 354 0.4× 177 0.4× 150 0.6× 168 0.7× 43 0.3× 19 581
Ralph F. DiCamelli United States 9 373 0.5× 246 0.5× 137 0.5× 77 0.3× 45 0.3× 12 673
Isabel Hervías Spain 15 153 0.2× 244 0.5× 411 1.6× 151 0.6× 78 0.5× 19 864
Carol S. Surowy United States 27 239 0.3× 328 0.7× 859 3.4× 263 1.1× 59 0.4× 51 1.6k
Wei-Yi Ong Singapore 17 219 0.3× 274 0.6× 245 1.0× 225 0.9× 11 0.1× 21 935
Haleli Sharir United States 14 641 0.8× 419 0.8× 514 2.0× 75 0.3× 35 0.2× 17 1.2k
George Grayson United States 11 361 0.5× 231 0.5× 239 0.9× 93 0.4× 129 0.9× 12 793

Countries citing papers authored by Hongfeng Deng

Since Specialization
Citations

This map shows the geographic impact of Hongfeng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfeng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfeng Deng more than expected).

Fields of papers citing papers by Hongfeng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongfeng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfeng Deng. The network helps show where Hongfeng Deng may publish in the future.

Co-authorship network of co-authors of Hongfeng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongfeng Deng. A scholar is included among the top collaborators of Hongfeng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongfeng Deng. Hongfeng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Patel, Priyal, Saikat Manna, Ryan F. Landis, et al.. (2025). Potent Liver‐Tropic mRNA Lipid Nanoparticles: ApoE‐Mediated Delivery Through a Low‐Density Lipoprotein Receptor Independent Uptake Mechanism. Advanced Materials. e17893–e17893.
2.
Haensler, Jean, et al.. (2025). Not so cold! Improving the thermostability of mRNA vaccines. Expert Review of Vaccines. 24(1). 1149–1162.
3.
Patel, Priyal, Ayed Allawzi, Saswata Karmakar, et al.. (2023). Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery. Drug Delivery and Translational Research. 14(2). 360–372. 30 indexed citations
4.
Deng, Hongfeng, et al.. (2013). Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. ACS Medicinal Chemistry Letters. 4(10). 942–947. 17 indexed citations
5.
Evindar, Ghotas, et al.. (2012). Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. Bioorganic & Medicinal Chemistry Letters. 23(2). 472–475. 2 indexed citations
6.
Deng, Hongfeng. (2010). Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors. Expert Opinion on Drug Discovery. 5(10). 961–993. 27 indexed citations
7.
Sit, S.Y., Robert L. Bertekap, Kai Xie, et al.. (2007). Novel inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 17(12). 3287–3291. 52 indexed citations
8.
Deng, Hongfeng, Thomas D. Bannister, Lei Jin, et al.. (2006). Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine. Bioorganic & Medicinal Chemistry Letters. 16(11). 3049–3054. 53 indexed citations
10.
Lin, Jian, Hongfeng Deng, Lei Jin, et al.. (2006). Design, Synthesis, and Biological Evaluation of Peptidomimetic Inhibitors of Factor XIa as Novel Anticoagulants. Journal of Medicinal Chemistry. 49(26). 7781–7791. 58 indexed citations
11.
Deng, Hongfeng, Andrew N. Gifford, A. M. Zvonok, et al.. (2005). Potent Cannabinergic Indole Analogues as Radioiodinatable Brain Imaging Agents for the CB1 Cannabinoid Receptor. Journal of Medicinal Chemistry. 48(20). 6386–6392. 34 indexed citations
12.
Ibrahim, Mohab, Hongfeng Deng, A. M. Zvonok, et al.. (2003). Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS. Proceedings of the National Academy of Sciences. 100(18). 10529–10533. 395 indexed citations
13.
Malan, Philip T., Mohab Ibrahim, Hongfeng Deng, et al.. (2001). CB2 cannabinoid receptor-mediated peripheral antinociception. Pain. 93(3). 239–245. 332 indexed citations
14.
Deng, Hongfeng. (2000). Design and synthesis of selective cannabinoid receptor ligands: Aminoalkylindole and other heterocyclic analogs. OpenCommons - UConn (University of Connecticut). 2 indexed citations
15.
Landsman, Robert S, Alexandros Makriyannis, Hongfeng Deng, et al.. (1998). AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Life Sciences. 62(9). PL109–PL113. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026